Role of oncogenes and tumor suppressor genes in multistage carcinogenesis

S. H. Yuspa, A. A. Dlugosz, C. K. Cheng, M. F. Denning, T. Tennenbaum, Adam Bleier Glick, W. C. Weinberg

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The introduction of the techniques of molecular biology as tools to study skin carcinogenesis has provided more precise localization of biochemical pathways regulate the tumor phenotype. This approach has identified genetic changes that are characteristic of each of the specific stages of squamous cancer pathogenesis: initiation, exogenous promotion, premalignant progression, and malignant conversion. Initiation can result from mutations in a single gene, and the allele of the ras gene family has been identified as a frequent site for initiating mutations. Heterozygous activating mutations in c-ras(Ha) are dominant, and affected keratinocytes hyperproliferate and are resistant to signals for terminal differentiation. An important pathway impacted by c-ras(Ha) activation is the protein kinase C (PKC) pathway, a major regulator of differentiation. Increased activity of PKCα and suppression of PKCδ by tyrosine phosphorylation contribute to the phenotypic consequences of ras(Ha) gene activation in keratinocytes. Tumor promoters disturb epidermal homeostasis and cause selective clonal expansion of initiated cells to produce multiple benign squamous papillomas. Resistance to differentiation and enhanced growth rate of initiated cells impart a growth advantage when the epidermis is exposed to promoters. The frequency of premalignant progression varies among papillomas, and subpopulations at high risk for progression have been identified. These high-risk papillomas overexpress the α6β4 integrin and are deficient in transforming growth factor β1 and β2 peptides, two changes associated with a very high proliferation rate in this subset of tumors. The introduction of an oncogenic ras(Ha) gene into epidermal cells derived from transgenic mice with a null mutation in the TGFβ1 gene have an accelerated rate of malignant progression when examined in vivo. Thus members of the TGFβ gene family contribute a tumor-suppressor function in carcinogenesis. Accelerated malignant progression is also found with v-ras(Ha) transduced keratinocytes from skin of mice with a null mutation in the p53 gene. The similarities in risk for malignant conversion by initiated keratinocytes from TGβ1 and p53 null geneotypes suggest that a common, growth-related pathway may underly the tumor-suppressive functions of these proteins in the skin carcinogenesis model.

Original languageEnglish (US)
Pages (from-to)S90-S95
JournalJournal of Investigative Dermatology
Volume103
Issue number5 SUPPL.
DOIs
StatePublished - Jan 1 1994

Fingerprint

Tumor Suppressor Genes
Oncogenes
Tumors
Carcinogenesis
Keratinocytes
Genes
Papilloma
Mutation
Protein Kinase C
ras Genes
Neoplasms
Skin
Growth
p53 Genes
Transforming Growth Factors
Chemical activation
Epidermis
Integrins
Carcinogens
Transgenic Mice

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Yuspa, S. H., Dlugosz, A. A., Cheng, C. K., Denning, M. F., Tennenbaum, T., Glick, A. B., & Weinberg, W. C. (1994). Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. Journal of Investigative Dermatology, 103(5 SUPPL.), S90-S95. https://doi.org/10.1038/jid.1994.16
Yuspa, S. H. ; Dlugosz, A. A. ; Cheng, C. K. ; Denning, M. F. ; Tennenbaum, T. ; Glick, Adam Bleier ; Weinberg, W. C. / Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. In: Journal of Investigative Dermatology. 1994 ; Vol. 103, No. 5 SUPPL. pp. S90-S95.
@article{7a90b387bfb04757b3d5084eb510a1d9,
title = "Role of oncogenes and tumor suppressor genes in multistage carcinogenesis",
abstract = "The introduction of the techniques of molecular biology as tools to study skin carcinogenesis has provided more precise localization of biochemical pathways regulate the tumor phenotype. This approach has identified genetic changes that are characteristic of each of the specific stages of squamous cancer pathogenesis: initiation, exogenous promotion, premalignant progression, and malignant conversion. Initiation can result from mutations in a single gene, and the allele of the ras gene family has been identified as a frequent site for initiating mutations. Heterozygous activating mutations in c-ras(Ha) are dominant, and affected keratinocytes hyperproliferate and are resistant to signals for terminal differentiation. An important pathway impacted by c-ras(Ha) activation is the protein kinase C (PKC) pathway, a major regulator of differentiation. Increased activity of PKCα and suppression of PKCδ by tyrosine phosphorylation contribute to the phenotypic consequences of ras(Ha) gene activation in keratinocytes. Tumor promoters disturb epidermal homeostasis and cause selective clonal expansion of initiated cells to produce multiple benign squamous papillomas. Resistance to differentiation and enhanced growth rate of initiated cells impart a growth advantage when the epidermis is exposed to promoters. The frequency of premalignant progression varies among papillomas, and subpopulations at high risk for progression have been identified. These high-risk papillomas overexpress the α6β4 integrin and are deficient in transforming growth factor β1 and β2 peptides, two changes associated with a very high proliferation rate in this subset of tumors. The introduction of an oncogenic ras(Ha) gene into epidermal cells derived from transgenic mice with a null mutation in the TGFβ1 gene have an accelerated rate of malignant progression when examined in vivo. Thus members of the TGFβ gene family contribute a tumor-suppressor function in carcinogenesis. Accelerated malignant progression is also found with v-ras(Ha) transduced keratinocytes from skin of mice with a null mutation in the p53 gene. The similarities in risk for malignant conversion by initiated keratinocytes from TGβ1 and p53 null geneotypes suggest that a common, growth-related pathway may underly the tumor-suppressive functions of these proteins in the skin carcinogenesis model.",
author = "Yuspa, {S. H.} and Dlugosz, {A. A.} and Cheng, {C. K.} and Denning, {M. F.} and T. Tennenbaum and Glick, {Adam Bleier} and Weinberg, {W. C.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1038/jid.1994.16",
language = "English (US)",
volume = "103",
pages = "S90--S95",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5 SUPPL.",

}

Yuspa, SH, Dlugosz, AA, Cheng, CK, Denning, MF, Tennenbaum, T, Glick, AB & Weinberg, WC 1994, 'Role of oncogenes and tumor suppressor genes in multistage carcinogenesis', Journal of Investigative Dermatology, vol. 103, no. 5 SUPPL., pp. S90-S95. https://doi.org/10.1038/jid.1994.16

Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. / Yuspa, S. H.; Dlugosz, A. A.; Cheng, C. K.; Denning, M. F.; Tennenbaum, T.; Glick, Adam Bleier; Weinberg, W. C.

In: Journal of Investigative Dermatology, Vol. 103, No. 5 SUPPL., 01.01.1994, p. S90-S95.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of oncogenes and tumor suppressor genes in multistage carcinogenesis

AU - Yuspa, S. H.

AU - Dlugosz, A. A.

AU - Cheng, C. K.

AU - Denning, M. F.

AU - Tennenbaum, T.

AU - Glick, Adam Bleier

AU - Weinberg, W. C.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The introduction of the techniques of molecular biology as tools to study skin carcinogenesis has provided more precise localization of biochemical pathways regulate the tumor phenotype. This approach has identified genetic changes that are characteristic of each of the specific stages of squamous cancer pathogenesis: initiation, exogenous promotion, premalignant progression, and malignant conversion. Initiation can result from mutations in a single gene, and the allele of the ras gene family has been identified as a frequent site for initiating mutations. Heterozygous activating mutations in c-ras(Ha) are dominant, and affected keratinocytes hyperproliferate and are resistant to signals for terminal differentiation. An important pathway impacted by c-ras(Ha) activation is the protein kinase C (PKC) pathway, a major regulator of differentiation. Increased activity of PKCα and suppression of PKCδ by tyrosine phosphorylation contribute to the phenotypic consequences of ras(Ha) gene activation in keratinocytes. Tumor promoters disturb epidermal homeostasis and cause selective clonal expansion of initiated cells to produce multiple benign squamous papillomas. Resistance to differentiation and enhanced growth rate of initiated cells impart a growth advantage when the epidermis is exposed to promoters. The frequency of premalignant progression varies among papillomas, and subpopulations at high risk for progression have been identified. These high-risk papillomas overexpress the α6β4 integrin and are deficient in transforming growth factor β1 and β2 peptides, two changes associated with a very high proliferation rate in this subset of tumors. The introduction of an oncogenic ras(Ha) gene into epidermal cells derived from transgenic mice with a null mutation in the TGFβ1 gene have an accelerated rate of malignant progression when examined in vivo. Thus members of the TGFβ gene family contribute a tumor-suppressor function in carcinogenesis. Accelerated malignant progression is also found with v-ras(Ha) transduced keratinocytes from skin of mice with a null mutation in the p53 gene. The similarities in risk for malignant conversion by initiated keratinocytes from TGβ1 and p53 null geneotypes suggest that a common, growth-related pathway may underly the tumor-suppressive functions of these proteins in the skin carcinogenesis model.

AB - The introduction of the techniques of molecular biology as tools to study skin carcinogenesis has provided more precise localization of biochemical pathways regulate the tumor phenotype. This approach has identified genetic changes that are characteristic of each of the specific stages of squamous cancer pathogenesis: initiation, exogenous promotion, premalignant progression, and malignant conversion. Initiation can result from mutations in a single gene, and the allele of the ras gene family has been identified as a frequent site for initiating mutations. Heterozygous activating mutations in c-ras(Ha) are dominant, and affected keratinocytes hyperproliferate and are resistant to signals for terminal differentiation. An important pathway impacted by c-ras(Ha) activation is the protein kinase C (PKC) pathway, a major regulator of differentiation. Increased activity of PKCα and suppression of PKCδ by tyrosine phosphorylation contribute to the phenotypic consequences of ras(Ha) gene activation in keratinocytes. Tumor promoters disturb epidermal homeostasis and cause selective clonal expansion of initiated cells to produce multiple benign squamous papillomas. Resistance to differentiation and enhanced growth rate of initiated cells impart a growth advantage when the epidermis is exposed to promoters. The frequency of premalignant progression varies among papillomas, and subpopulations at high risk for progression have been identified. These high-risk papillomas overexpress the α6β4 integrin and are deficient in transforming growth factor β1 and β2 peptides, two changes associated with a very high proliferation rate in this subset of tumors. The introduction of an oncogenic ras(Ha) gene into epidermal cells derived from transgenic mice with a null mutation in the TGFβ1 gene have an accelerated rate of malignant progression when examined in vivo. Thus members of the TGFβ gene family contribute a tumor-suppressor function in carcinogenesis. Accelerated malignant progression is also found with v-ras(Ha) transduced keratinocytes from skin of mice with a null mutation in the p53 gene. The similarities in risk for malignant conversion by initiated keratinocytes from TGβ1 and p53 null geneotypes suggest that a common, growth-related pathway may underly the tumor-suppressive functions of these proteins in the skin carcinogenesis model.

UR - http://www.scopus.com/inward/record.url?scp=0028143668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028143668&partnerID=8YFLogxK

U2 - 10.1038/jid.1994.16

DO - 10.1038/jid.1994.16

M3 - Article

VL - 103

SP - S90-S95

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5 SUPPL.

ER -